53 results on '"Trama Annalisa"'
Search Results
2. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study
3. Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group
4. Survival of European adolescents and young adults diagnosed with cancer in 2010–2014
5. Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN
6. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study
7. Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities
8. Incidence and prognosis of Cutaneous Melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results
9. HeNeCOn: An ontology for integrative research in Head and Neck cancer
10. Solutions for optimal care and research for children and adolescents with extremely rare cancers developed within the Joint Action for Rare Cancers (JARC)
11. Epidemiology of rare cancers in India and South Asian countries – remembering the forgotten
12. Increased incidence of rare cancers and varied age distributions by cancer group: A population-based cancer registry study in Hiroshima Prefecture, Japan
13. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study
14. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting
15. Kaposi sarcoma incidence, survival and trends: Data from the information network on rare cancers in Europe (RARECAREnet)
16. Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet)
17. Rare cancers are not rare in Asia as well: The rare cancer burden in East Asia
18. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
19. Priorities on rare cancers’ policy in National Cancer Control Plans (NCCPs): A review conducted within the framework of EU-JARC Joint-Action
20. Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU)
21. Changes in life expectancy for cancer patients over time since diagnosis
22. The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma
23. Soft tissue sarcoma in Italy: From epidemiological data to clinical networking to improve patient care and outcomes
24. Cancer of the anal region
25. Treatment challenges in and outside a network setting: Head and neck cancers
26. Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference
27. Networking in rare cancers: What was done, what's next
28. Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting
29. Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours
30. Epidemiology of rare cancers and inequalities in oncologic outcomes
31. Treatment challenges in and outside a network setting: Soft tissue sarcomas
32. Survival of adults with cancers of bone or soft tissue in Europe—Report from the EUROCARE-5 study
33. Bayesian estimates of the incidence of rare cancers in Europe
34. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?
35. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study
36. Improving treatment results with reference centres for rare cancers: where do we stand?
37. Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study
38. Survival of European adolescents and young adults diagnosed with cancer in 2000–07: population-based data from EUROCARE-5
39. Diagnosis and management of typical and atypical lung carcinoids
40. Thymoma and thymic carcinomas
41. EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report
42. Direct and indirect effects of COVID-19 on short-term mortality of breast cancer patients
43. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study
44. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study
45. Methodological aspects of estimating rare cancer prevalence in Europe: The experience of the RARECARE project
46. Embryonal cancers in Europe
47. Epidemiology of glial and non-glial brain tumours in Europe
48. The European Network for Sinonasal Cancer Research (EUSICA) – A pan-European initiative targeting a group of orphan tumours
49. Rare cancers are not so rare: The rare cancer burden in Europe
50. RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.